Evan M. Cale, Ph.D. - Publications

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 
Area:
Immunology

10/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Krebs SJ, Kwon YD, Schramm CA, Law WH, Donofrio G, Zhou KH, Gift S, Dussupt V, Georgiev IS, Schätzle S, McDaniel JR, Lai YT, Sastry M, Zhang B, Jarosinski MC, ... ... Cale EM, et al. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual. Immunity. PMID 30876875 DOI: 10.1016/J.Immuni.2019.02.008  0.56
2017 Alam SM, Aussedat B, Vohra Y, Ryan Meyerhoff R, Cale EM, Walkowicz WE, Radakovich NA, Anasti K, Armand L, Parks R, Sutherland L, Scearce R, Joyce MG, Pancera M, Druz A, et al. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide. Science Translational Medicine. 9. PMID 28298421 DOI: 10.1126/Scitranslmed.Aai7521  0.56
2016 Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody. Science (New York, N.Y.). 352: 828-33. PMID 27174988 DOI: 10.1126/Science.Aae0474  0.56
2015 Doria-Rose NA, Bhiman JN, Roark RS, Schramm CA, Gorman J, Chuang GY, Pancera M, Cale EM, Ernandes MJ, Louder MK, Asokan M, Bailer RT, Druz A, Fraschilla IR, Garrett NJ, et al. A new member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency. Journal of Virology. PMID 26468542 DOI: 10.1128/Jvi.01791-15  0.56
2011 Cale EM, Bazick HS, Rianprakaisang TA, Alam SM, Letvin NL. Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding. Journal of Immunology (Baltimore, Md. : 1950). 187: 3300-13. PMID 21841125 DOI: 10.4049/Jimmunol.1101080  0.56
2011 Hulot SL, Cale EM, Korber BT, Letvin NL. Vaccine-induced CD8+ T lymphocytes of rhesus monkeys recognize variant forms of an HIV epitope but do not mediate optimal functional activity. Journal of Immunology (Baltimore, Md. : 1950). 186: 5663-74. PMID 21490161 DOI: 10.4049/Jimmunol.1100287  0.56
2011 Cale EM, Hraber P, Giorgi EE, Fischer W, Bhattacharya T, Leitner T, Yeh WW, Gleasner C, Green LD, Han CS, Korber B, Letvin NL. Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection. Journal of Virology. 85: 3746-57. PMID 21307185 DOI: 10.1128/Jvi.02420-10  0.56
2006 Yeh WW, Cale EM, Jaru-Ampornpan P, Lord CI, Peyerl FW, Letvin NL. Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations. Journal of Virology. 80: 8168-77. PMID 16873273 DOI: 10.1128/Jvi.00068-06  0.56
2004 Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. The Journal of Biological Chemistry. 279: 43479-86. PMID 15292184 DOI: 10.1074/Jbc.M407640200  0.56
2004 Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. Journal of Virology. 78: 6409-19. PMID 15163734 DOI: 10.1128/Jvi.78.12.6409-6419.2004  0.56
Low-probability matches
2021 Wang L, Zhou T, Zhang Y, Yang ES, Schramm CA, Shi W, Pegu A, Oloniniyi OK, Henry AR, Darko S, Narpala SR, Hatcher C, Martinez DR, Tsybovsky Y, Phung E, ... ... Cale EM, et al. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science (New York, N.Y.). PMID 34210892 DOI: 10.1126/science.abh1766  0.01
2021 Simonich C, Shipley MM, Doepker L, Gobillot T, Garrett M, Cale EM, Hennessy B, Itell H, Chohan V, Doria-Rose N, Nduati R, Overbaugh J. A diverse collection of B cells responded to HIV infection in infant BG505. Cell Reports. Medicine. 2: 100314. PMID 34195680 DOI: 10.1016/j.xcrm.2021.100314  0.01
2021 Wang L, Zhou T, Zhang Y, Yang ES, Schramm CA, Shi W, Pegu A, Oloninyi OK, Ransier A, Darko S, Narpala SR, Hatcher C, Martinez DR, Tsybovsky Y, Phung E, ... ... Cale EM, et al. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants. Biorxiv : the Preprint Server For Biology. PMID 33655252 DOI: 10.1101/2021.02.25.432969  0.01
2020 Cale EM, Bai H, Bose M, Messina MA, Colby D, Sanders-Buell E, Dearlove BL, Li Y, Engeman E, Silas D, O'Sullivan AM, Mann B, Pinyakorn S, Intasan J, Benjapornpong K, et al. Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound. The Journal of Clinical Investigation. PMID 32182219 DOI: 10.1172/JCI134395  0.01
2018 Crooks ET, Grimley SL, Cully M, Osawa K, Dekkers G, Saunders K, Rämisch S, Menis S, Schief WR, Doria-Rose N, Haynes B, Murrell B, Cale EM, Pegu A, Mascola JR, et al. Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation. Plos Pathogens. 14: e1007024. PMID 29718999 DOI: 10.1371/Journal.Ppat.1007024  0.01
2017 Cale EM, Gorman J, Radakovich NA, Crooks ET, Osawa K, Tong T, Li J, Nagarajan R, Ozorowski G, Ambrozak DR, Asokan M, Bailer RT, Bennici AK, Chen X, Doria-Rose NA, et al. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop. Immunity. 46: 777-791.e10. PMID 28514685 DOI: 10.1016/J.Immuni.2017.04.011  0.01
2007 Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS. Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt Journal of Virology. 81: 3673-3673. DOI: 10.1128/jvi.00145-07  0.01
2006 Cale EM, Lilienfeld SO. Psychopathy factors and risk for aggressive behavior: a test of the "threatened egotism" hypothesis. Law and Human Behavior. 30: 51-74. PMID 16729208 DOI: 10.1007/S10979-006-9004-5  0.01
2006 Cale EM. A quantitative review of the relations between the "Big 3" higher order personality dimensions and antisocial behavior Journal of Research in Personality. 40: 250-284. DOI: 10.1016/J.Jrp.2005.01.001  0.01
2003 Skeem JL, Poythress N, Edens JF, Lilienfeld SO, Cale EM. Psychopathic personality or personalities? Exploring potential variants of psychopathy and their implications for risk assessment Aggression and Violent Behavior. 8: 513-546. DOI: 10.1016/S1359-1789(02)00098-8  0.01
2003 Cale EM, Lilienfeld SO. What Every Forensic Psychologist Should Know about Psychopathic Personality Handbook of Forensic Psychology: Resource For Mental Health and Legal Professionals. 395-428. DOI: 10.1016/B978-012524196-0/50019-X  0.01
2002 Cale EM, Lilienfeld SO. Sex differences in psychopathy and antisocial personality disorder. A review and integration. Clinical Psychology Review. 22: 1179-207. PMID 12436810 DOI: 10.1016/S0272-7358(01)00125-8  0.01
2002 Cale EM, Lilienfeld SO. Histrionic personality disorder and antisocial personality disorder: sex-differentiated manifestations of psychopathy? Journal of Personality Disorders. 16: 52-72. PMID 11881161 DOI: 10.1521/Pedi.16.1.52.22557  0.01
2001 Baylis GC, Cale EM. The figure has a shape, but the ground does not: evidence from a priming paradigm. Journal of Experimental Psychology. Human Perception and Performance. 27: 633-43. PMID 11424650 DOI: 10.1037//0096-1523.27.3.633  0.01
Hide low-probability matches.